Association of CYP2C19*2 polymorphisms and high on-treatment platelet reactivity in acute myocardial infarction or coronary artery in-stent restenosis patients during dual antiplatelet therapy
Objective: Cytochrome CYP2C19 mutant allele is associated with high on-treatment platelet reactivity (HTPR) after standard clopidogrel treatment, which is accompanied by an increased risk of ischemic events. This study assesses the association of CYP2C19 mutant allele with HTRR and its response to a...
Saved in:
Main Authors: | Yawei Yang (Author), Wei Zhang (Author), Pan Li (Author), Ying Gu (Author), Liping Ma (Author), Min Fan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients
by: Zhang M, et al.
Published: (2020) -
Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis
by: Ivan S. Alferiev, et al.
Published: (2024) -
Persistent risk of vascular complications and efficacy of prolonged dual antiplatelet therapy after myocardial infarction
by: I. S. Yavelo
Published: (2022) -
Targeting the epigenome in in-stent restenosis: from mechanisms to therapy
by: Xi Yang, et al.
Published: (2021) -
Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Erkan Yıldırım, et al.
Published: (2017)